Life SciencesPharmaceuticalsPharmaceuticals Company Reports

Astellas Pharma Inc.

Lowest Prices Guaranteed Length Publisher Published Date SKU
from $175 51 Pages MarketLine November, 2015 MTLN5797876
Lowest Prices Guaranteed
Price from $175
Length 51 Pages
Publisher MarketLine
Published Date November, 2015
SKU MTLN5797876

Astellas Pharma Inc. - Strategy and SWOT Report,

- is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Features:

  • Detailed information on Astellas Pharma Inc. required for business and competitor intelligence needs
  • A study of the major internal and external factors affecting Astellas Pharma Inc. in the form of a SWOT analysis
  • An in-depth view of the business model of Astellas Pharma Inc. including a breakdown and examination of key business segments
  • Intelligence on Astellas Pharma Inc.’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
  • News about Astellas Pharma Inc., such as business expansion, restructuring, and contract wins
  • Large number of easy-to-grasp charts and graphs that present important data and key trends
Highlights:

Astellas Pharma (Astellas or 'the company') is engaged in the manufacture, marketing, import and export of pharmaceuticals and related products. The company operates in Japan, Asia, the Americas, Europe, Middle East, and Africa (EMEA) and Oceania. It is headquartered in Tokyo, Japan and employed 17,649 people as of March 31, 2014.Reasons to Purchase:

  • Gain understanding of Astellas Pharma Inc. and the factors that influence its strategies
  • Track strategic initiatives of the company and latest corporate news and actions
  • Assess Astellas Pharma Inc. as a prospective partner, vendor or supplier
  • Support sales activities by understanding your customers' businesses better
  • Stay up to date on Astellas Pharma Inc.’s business structure, strategy and prospects


    • Company Snapshot
    Astellas Pharma Inc.: Company Overview
    Astellas Pharma Inc.: Overview and Key Facts
    Astellas Pharma Inc.: Overview
    Astellas Pharma Inc.: Key Facts
    Astellas Pharma Inc.: Key Employees
    Astellas Pharma Inc.: Key Employee Biographies
    Astellas Pharma Inc.: Major Products and Services
    Astellas Pharma Inc.: Company History
    Astellas Pharma Inc.: Management Statement
    Astellas Pharma Inc.: Locations and Subsidiaries
    Astellas Pharma Inc.: Key Competitors
    Astellas Pharma Inc.: Company Analysis
    Astellas Pharma Inc.: Business Description
    Astellas Pharma Inc.: SWOT Analysis
    Astellas Pharma Inc.: SWOT Overview
    Astellas Pharma Inc.: Strengths
    Astellas Pharma Inc.: Weaknesses
    Astellas Pharma Inc.: Opportunities
    Astellas Pharma Inc.: Threats
    Astellas Pharma Inc.: Corporate Financial Deals Activity
    Astellas Pharma Inc.: Financial Deals Overview
    Astellas Pharma Inc.: Targets and Partners
    Astellas Pharma Inc.: Top Deals 2011 - 2015YTD*
    Astellas Pharma Inc.: Advisors
    Astellas Pharma Inc.: Top Legal Advisors
    Astellas Pharma Inc.: Mergers and Acquisitions
    Astellas Pharma Inc.: Corporate Venturing
    Astellas Pharma Inc.: Partnership
    Astellas Pharma Inc.: Divestments
    Astellas Pharma Inc.: Recent Developments
    Astellas Pharma Inc.: News and Events Summary
    Astellas Pharma Inc.: Business Expansion
    Astellas Pharma Inc.: Contracts
    Astellas Pharma Inc.: Corporate Governance
    Astellas Pharma Inc.: Regulatory and Legal Events
    Astellas Pharma Inc.: Research & Development
    Appendix
    Contact Us
    Methodology
    Definitions
    About Market Line
    List of Tables
    Table 1: Astellas Pharma Inc.: Key Facts
    Table 2: Astellas Pharma Inc.: Key Employees
    Table 4: Astellas Pharma Inc.: Key Competitors
    Table 5: Astellas Pharma Inc.: Deal Activity by Deal Type - Volume (TTM*)
    Table 6: Astellas Pharma Inc.: Deal Activity by Deal Type - Volume (2011 - YTD*2015)
    Table 7: Astellas Pharma Inc.: M&A Average Deal Size - Value (US$m)
    Table 8: Astellas Pharma Inc.: Targets and Partners
    Table 9: Astellas Pharma Inc.: Top Deals 2011 - 2015YTD*
    Table 10: Astellas Pharma Inc.: Legal Advisor Ranking by Value (US$m)
    Table 11: Astellas Pharma Inc.: M&A Volume and Value Trend (2011 - YTD*2015)
    Table 12: Astellas Pharma Inc.: M&A Activity by Geography (2011 - YTD*2015)
    Table 13: Astellas Pharma Inc.: Corporate Venturing Volume and Value Trend (2011 - YTD*2015)
    Table 14: Astellas Pharma Inc.: Corporate Venturing by Geography (2011 - YTD*2015)
    Table 15: Astellas Pharma Inc.: Partnership Volume and Value Trend (2011 - YTD*2015)
    Table 16: Astellas Pharma Inc.: Partnership Trend by Deal Type (2011 - YTD*2015)
    Table 17: Astellas Pharma Inc.: Divestments Volume and Value Trend (2011 - YTD*2015)
    Table 18: Astellas Pharma Inc.: Divestments by Geography (2011 - YTD*2015)
    Table 19: Astellas Pharma Inc.: News and Events Summary
    Table 20: Astellas Pharma Inc.: Business Expansion
    Table 21: Astellas Pharma Inc.: Contracts
    Table 22: Astellas Pharma Inc.: Corporate Governance
    Table 23: Astellas Pharma Inc.: Regulatory and Legal Events
    Table 24: Astellas Pharma Inc.: Research & Development
    List of Figures
    Figure 1: Astellas Pharma Inc.: Deal Activity by Deal Type - Volume (TTM*)
    Figure 2: Astellas Pharma Inc.: Deal Activity by Deal Type - Volume (2011 - YTD*2015)
    Figure 3: Astellas Pharma Inc.: M&A Average Deal Size - Value (US$m)
    Figure 4: Astellas Pharma Inc.: M&A Volume and Value Trend (2011 - YTD*2015)
    Figure 5: Astellas Pharma Inc.: M&A Activity by Geography (2011 - YTD*2015)
    Figure 6: Astellas Pharma Inc.: Corporate Venturing Volume and Value Trend (2011 - YTD*2015)
    Figure 7: Astellas Pharma Inc.: Corporate Venturing by Geography (2011 - YTD*2015)
    Figure 8: Astellas Pharma Inc.: Partnership Volume and Value Trend (2011 - YTD*2015)
    Figure 9: Astellas Pharma Inc.: Partnership Trend by Deal Type (2011 - YTD*2015)
    Figure 10: Astellas Pharma Inc.: Divestments Volume and Value Trend (2011 - YTD*2015)
    Figure 11: Astellas Pharma Inc.: Divestments by Geography (2011 - YTD*2015)

    $175
    $437.50
     
    Research assistance
    US: 800.298.5699
    Int'l: +1.240.747.3093
    Download our eBook: How to Succeed Using Market Research

    Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

    Download eBook

    Other tasks